GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emergent BioSolutions Inc (LTS:0IGA) » Definitions » Other Current Liabilities

Emergent BioSolutions (LTS:0IGA) Other Current Liabilities : $84 Mil (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Emergent BioSolutions Other Current Liabilities?

Emergent BioSolutions's other current liabilities for the quarter that ended in Dec. 2024 was $84 Mil.

Emergent BioSolutions's quarterly other current liabilities increased from Jun. 2024 ($91 Mil) to Sep. 2024 ($131 Mil) but then declined from Sep. 2024 ($131 Mil) to Dec. 2024 ($84 Mil).

Emergent BioSolutions's annual other current liabilities declined from Dec. 2022 ($133 Mil) to Dec. 2023 ($107 Mil) and declined from Dec. 2023 ($107 Mil) to Dec. 2024 ($84 Mil).


Emergent BioSolutions Other Current Liabilities Historical Data

The historical data trend for Emergent BioSolutions's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emergent BioSolutions Other Current Liabilities Chart

Emergent BioSolutions Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 167.70 161.80 133.20 106.80 83.80

Emergent BioSolutions Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 106.80 56.50 91.40 130.90 83.80

Emergent BioSolutions Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


Emergent BioSolutions Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Emergent BioSolutions's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Emergent BioSolutions Business Description

Traded in Other Exchanges
Address
300 Professional Drive, Gaithersburg, MD, USA, 20879
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

Emergent BioSolutions Headlines

No Headlines